<2-Aethyl-naphthyl-(1)>-amin | 36357-84-3

• 分子结构分类: 有机化合物 - 苯类化合物 - 萘
• 英文名称: <2-Aethyl-naphthyl-(1)>-amin
• 英文别名: 2-ethyl-[1]naphthylamine；2-Aethyl-[1]naphthylamin；1-Amino-2-aethyl-naphthalin；2-Ethylnaphthyl amine；2-ethylnaphthalen-1-amine
• CAS: 36357-84-3
• 化学式: C₁₂H₁₃N
• 分子量: 171.242
• InChiKey: XHOQGQOCVBMAFH-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.3
• 重原子数：
  13
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.17
• 拓扑面积：
  26
• 氢给体数：
  1
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  <2-Aethyl-naphthyl-(1)>-amin 在 甲基锂 作用下， 反应 26.0h， 生成 N,N-Diethyl(2-ethyl-1-naphthyl)amine
  参考文献：
  名称：

  Conformational studies by dynamic NMR. 40. Conformational atropoisomerism in highly hindered naphthylamines

  摘要：

  N,N-Dialkyl-1-naphthylamines substituted by alkyl groups R (R = Me, Et, i-Pr, t-Bu) in position 2 display anisochronous NMR signals owing to their twisted conformational arrangement. These conformers are enantiomerically related (conformational atropoisomers), and variable temperature NMR measurements allowed the enantiomerization barriers to be determined. The barriers increase with the increasing dimension of the substituents (covering the range 15.7-23.0 kcal mol-1), and the observed trend was reproduced by Molecular Mechanics calculations. The calculations also gave indications upon the structure of the conformers that correspond to energy minima. The final choice among the possible conformations could be achieved by comparing the computed interprotonic distances with the results of NOE experiments.

  DOI：

  10.1021/jo00005a017
• 作为产物：
  描述：

  2-乙基萘 在 硝酸 、 铁粉 、 溶剂黄146 作用下， 生成 <2-Aethyl-naphthyl-(1)>-amin
  参考文献：
  名称：

  Levy, Comptes Rendus Hebdomadaires des Seances de l'Academie des Sciences, 1932, vol. 195, p. 801

  摘要：

  DOI：

文献信息

• [EN] METAL-LIGAND COMPLEXES AND CATALYSTS<br/>[FR] COMPLEXES MÉTAL-LIGAND ET CATALYSEURS
  申请人：DOW GLOBAL TECHNOLOGIES LLC

  公开号：WO2011102989A1

  公开（公告）日：2011-08-25

  The present invention generally relates to metal-ligand complexes, catalysts comprising or prepared from the metal-ligand complexes, processes of catalyzing olefin polymerization reactions with the catalysts to prepare polyolefins, polyolefins prepared thereby, processes of making the metal-ligand complexes and catalysts, and intermediate compounds useful therefor.

  本发明通常涉及金属配体络合物，包含或由金属配体络合物制备的催化剂，使用这些催化剂催化烯烃聚合反应以制备聚烯烃的过程，由此制备的聚烯烃，制备金属配体络合物和催化剂的过程，以及有用的中间化合物。
• [EN] NEW ORGANIC COMPOUNDS FOR ELECTROLUMINESCENCE AND ORGANIC ELECTROLUMINESCENT DEVICES USING THE SAME<br/>[FR] NOUVEAUX COMPOSES ORGANIQUES POUR L'ELECTROLUMINESCENCE ET DISPOSITIFS ELECTROLUMINESCENTS ORGANIQUES DANS LESQUELS ILS SONT UTILISES
  申请人：LG CHEMICAL LTD

  公开号：WO2003095445A1

  公开（公告）日：2003-11-20

  Disclosed is a novel group of compounds having a general structure of anthracene body substituted with at least one thiophenyl group, which can be further substituted with various substituent groups. These new compounds are generally compatible with organic electroluminescence. Also disclosed are organic electroluminescent devices and method of making the same. The organic electroluminescent devices include at least one of the compounds in various layers thereof. Organic electroluminescent devices employing the new compounds in their light-emitting layers show outstanding stability.

  揭示了一类新的化合物群，其具有一个蒽骨架的一般结构，并且至少被一种噻吩基团取代，该基团可以进一步被各种取代基团取代。这些新化合物通常与有机电致发光兼容。还揭示了有机电致发光器件以及其制备方法。有机电致发光器件包括其中的至少一种化合物在各种层中。在其发光层中使用新化合物的有机电致发光器件表现出出色的稳定性。
• [EN] PHOSPHINYL AMIDINE COMPOUNDS, METAL COMPLEXES, CATALYST SYSTEMS, AND THEIR USE TO OLIGOMERIZE OR POLYMERIZE OLEFINS<br/>[FR] COMPOSÉS DE PHOSPHINYLAMIDINE, COMPLEXES DE MÉTAL, SYSTÈMES DE CATALYSEUR, ET LEUR UTILISATION POUR OLIGOMÉRISER OU POLYMÉRISER DES OLÉFINES
  申请人：CHEVRON PHILLIPS CHEMICAL CO

  公开号：WO2011082192A1

  公开（公告）日：2011-07-07

  N2-phosphinyl amidine compounds, N2-phosphinyl amidinates, N2-phosphinyl amidine metal salt complexes, N2-phosphinyl amidinate metal salt complexes are described. Methods for making N2-phosphinyl amidine compounds, N2-phosphinyl amidinates, N2-phosphinyl amidine metal salt complexes, and N2-phosphinyl amidinate metal salt complexes are also disclosed. Catalyst systems utilizing the N2-phosphinyl amidine metal salt complexes and N2-phosphinyl amidinate metal salt complexes are also disclosed along with the use of the N2-phosphinyl amidine compounds, N2-phosphinyl amidinates, N2-phosphinyl amidine metal salt complexes, and N2-phosphinyl amidinate metal salt complexes for the oligomerization and/or polymerization of olefins.

  描述了N2-膦胺化合物、N2-膦胺酸盐、N2-膦胺金属盐络合物、N2-膦胺酸盐金属盐络合物。还公开了制备N2-膦胺化合物、N2-膦胺酸盐、N2-膦胺金属盐络合物和N2-膦胺酸盐金属盐络合物的方法。还公开了利用N2-膦胺金属盐络合物和N2-膦胺酸盐金属盐络合物的催化剂系统，以及利用N2-膦胺化合物、N2-膦胺酸盐、N2-膦胺金属盐络合物和N2-膦胺酸盐金属盐络合物进行烯烃的寡聚和/或聚合的用途。
• [EN] PHOSPHINYL FORMAMIDINE COMPOUNDS, METAL COMPLEXES, CATALYST SYSTEMS, AND THEIR USE TO OLIGOMERIZE OR POLYMERIZE OLEFINS<br/>[FR] COMPOSÉS PHOSPHINYL FORMAMIDINE, COMPLEXES MÉTALLIQUES, SYSTÈMES DE CATALYSEUR, ET LEUR UTILISATION POUR OLIGOMÉRISER OU POLYMÉRISER DES OLÉFINES
  申请人：CHEVRON PHILLIPS CHEMICAL CO

  公开号：WO2015094207A1

  公开（公告）日：2015-06-25

  N2-phosphinyl formamidine compounds and N2-phosphinyl formamidine metal salt complexes are described. Methods for making N2-phosphinyl formamidine compounds and N2-phosphinyl formamidine metal salt complexes are also disclosed. Catalyst systems utilizing the N2-phosphinyl formamidine metal salt complexes are also disclosed along with the use of the N2-phosphinyl amidine compounds and N2- phosphinyl amidinate metal salt complexes for the oligomerization and/or polymerization of olefins.

  描述了N2-磷酰基甲酰胺化合物和N2-磷酰基甲酰胺金属盐配合物。还公开了制备N2-磷酰基甲酰胺化合物和N2-磷酰基甲酰胺金属盐配合物的方法。还公开了利用N2-磷酰基甲酰胺金属盐配合物的催化剂体系，以及利用N2-磷酰基胺化合物和N2-磷酰基胺金属盐配合物进行烯烃的寡聚和/或聚合的用途。
• Drugs for the treatment of cardiac arrest and other shock states
  申请人：The Ohio State University

  公开号：US05527830A1

  公开（公告）日：1996-06-18

  The invention relates to new drugs for augmenting perfusion pressure administered during cardiopulmonary resuscitation and other shock states. The compounds include phenylethanolamines and imidazolines, and fluorinated derivatives thereof, which act on adrenergic receptors in patients. The compounds of the invention enhance neurologic outcome and survival, and decrease ventricular dysrhythmias in patients suffering cardiac arrest and other shock states, relative to the outcomes, survival, and post defibrillation ventricular dysrhythmias in conventional therapy for use in resuscitation.

  本发明涉及用于心肺复苏和其他休克状态下增加灌注压的新药物。该化合物包括苯乙醇胺和咪唑啉及其氟化衍生物，它们作用于患者的肾上腺素能受体。本发明的化合物可以增强患者的神经系统预后和生存率，并减少心室心律失常，相对于常规治疗中的除颤后预后、生存率和心室心律失常，适用于复苏。